CORONARIA HOIVA acquired by HUMANA
Context
Humana AB entered into a definitive agreement to acquire 100% of Coronaria Hoiva Oy to significantly expand its operational footprint in the Finnish market. This strategic acquisition was designed to integrate Coronaria Hoiva’s specialized residential care portfolio into Humana’s existing Finnish operations, creating a more diversified and robust platform for social care delivery. The transaction was financed through a combination of existing cash reserves and new credit facilities, and it received formal approval from the Finnish Competition and Consumer Authority in early April. The move aligned with Humana’s long-term strategy of consolidating the Nordic care market, providing an immediate positive contribution to the group's revenues and earnings per share while enhancing its ability to serve the growing Finnish aging population.
CORONARIA HOIVA, which reported an EBITDA margin of LOGIN in 2020, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.8x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Coronaria Hoiva Oy functions as a prominent Finnish provider of social care services, specializing in residential care for the elderly, individuals with disabilities, and mental health rehabilitation. At the time of the transaction, the company operated a high-quality network of care homes across Finland, maintaining a strong reputation for clinical excellence and personalized service delivery.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Similar deals in Healthcare & Pharma
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 04/2019 | COLISÉE | ARMONEA | BELGIUM | Health Providers | Colisée Group entered into a definitive agreement to acquire 100% of Armonea to create the fourth-largest elderly care operator in Europe. This transformative acquisition doubled Colisée’s size, resulting in a combined entity with a turnover of approximately €1 billion and a network of 270 facilities across five countries. The merger was strategically designed to capitalize on geographic complementarities, merging Colisée’s strong Mediterranean presence with Armonea’s market leadership in Northern Europe |
| 03/2019 | DOMUSVI | RESIDALYA | FRANCE | Health Providers | DomusVi entered into exclusive negotiations to acquire 100% of the capital of Residalya, in a move designed to significantly densify its territorial coverage within France. The transaction allowed DomusVi to absorb 35 additional facilities and roughly 2,630 beds, bringing its total capacity to over 17,000 beds and narrowing the gap with its primary market competitors. This strategic build-up was motivated by the need to reach a critical industrial scale, merging Residalya’s localized expertise and specialized assets—including the ownership of twelve of its residences—into DomusVi’s global operational platform |
| 04/2018 | INVESTINDUSTRIAL | LIFEBRAIN | ITALY | Health Providers | Investindustrial acquired a controlling stake in Lifebrain from the investment vehicle lb EK Management. The deal follows a period of intense growth supported by MCI Capital, during which the group established itself as a leading consolidator in the fragmented Italian laboratory market. The acquisition was structured through a Luxembourg vehicle, European Laboratory Services, and aimed to provide the capital and expertise necessary to professionalize the group and accelerate its aggressive acquisition strategy across Italy |
| 03/2018 | THE ADOLFSEN GROUP | FRÖSUNDA | SWEDEN | Health Providers | Pan-European private equity firm Hg has successfully completed the divestiture of its majority equity stake in Swedish care provider Frösunda Omsorg AB to Norway-based investment firm The Adolfsen Group. Executed through the holding company Brado—an investment vehicle owned by brothers Kristian and Roger Adolfsen—the transaction concludes a highly successful eight-year holding period for the sponsor. Throughout the targeted sale process, Hg was exclusively advised by investment bank Carnegie, acting as sole financial advisor |
| 03/2018 | ICV PARTNERS | OUTPATIENT IMAGING AFFILIATES | UNITED STATES | Health Providers | ICV Partners has acquired Outpatient Imaging Affiliates (OIA) from its founder, Frank Kyle, and MedCare Investment Funds, a family office. This acquisition represents a platform investment for ICV in the outpatient imaging sector. The firm identified OIA as a well-positioned player due to its partnership-based model with hospital systems, operational expertise, and successful track record of integrating new imaging centers. Given the highly fragmented nature of the US outpatient imaging market, ICV saw this transaction as an opportunity to pursue an active external growth strategy while continuing to drive organic growth |
| 01/2018 | PERMIRA | I-MED RADIOLOGY NETWORK | AUSTRALIA | Health Providers | Permira acquired I-MED from EQT Mid Market and its co-investors (GIC and CDPQ) in a competitive auction process. The transaction was structured as a majority buyout, with the existing management team, led by CEO Steven Rubic, rolling over equity and remaining at the helm. Under EQT's previous four-year ownership, I-MED had significantly expanded its footprint through hospital contracts and bolt-on acquisitions. Permira's entry was designed to drive the next phase of growth by further consolidating the fragmented Australian radiology market, investing in advanced imaging technologies, and exploring potential international expansion (including teleradiology) |
| 06/2017 | ICG / MANAGEMENT & PRIVATE INVESTORS | DOMUSVI | FRANCE | Health Providers | ICG and founder Yves Journel have entered into exclusive negotiations to acquire the majority stake in DomusVi from PAI Partners. The transaction follows a preemptive bid by ICG that successfully bypassed a formal auction process involving major international investors and sovereign funds. This deal marks a significant change in scale for the group, which was valued at less than €650 million in 2014. The acquisition is structured to maintain the existing high-yield bond financing, as the continued presence of ICG and the founder in the capital prevents the activation of change-of-control repayment clauses |
| 04/2017 | EQT PARTNERS | COLISÉE | FRANCE | Health Providers | IK Investment Partners, through its IK VIII Fund, reached an agreement with Eurazeo PME and the management team to acquire a majority stake in Colisée. The founding family and management team reinvested alongside IK, ensuring continuity of strategic direction and operational leadership. The investment thesis centres on supporting Colisée's continued growth through selective buy-and-build acquisitions in France and across Europe, as well as the development of innovative services for elderly people |
| 01/2017 | PARTNERS GROUP / PSP INVESTMENTS | CERBA HEALTHCARE | FRANCE | Health Providers | Partners Group and Canadian pension fund PSP entered exclusive negotiations to acquire Cerba from PAI Partners. The consortium beat out CVC and Apax, but most notably rejected a higher offer (>EUR2bn) from industrial player Cinven (owner of Synlab/Labco). Management preferred the financial sponsors to avoid massive cost synergies and restructuring. |
| 10/2016 | DOMUSVI | SARQUAVITAE | SPAIN | Health Providers | DomusVi has successfully acquired its Spanish competitor SARquavitae, previously held by a consortium of investment funds including Palamon Capital Partners and G Square Capital. This transformative build-up operation allows the group to become the number one player in the Spanish elderly care market. The strategic rationale centers on geographic diversification, as the target’s strong footprint in Catalonia and Madrid perfectly complements the acquirer’s existing position in Galicia. The integration adds 88 facilities and 11,000 beds to the group’s portfolio, bringing total pro forma revenues to approximately €1 |
REFERENCES
Valuation range: EV 50M - 150M EUR
Revenue range: 50M - 100M EUR
EBITDA range: 0M - 5M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of CORONARIA HOIVA by HUMANA are reserved for mynth community members. Register for free to unlock full data.
Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).
Acquirer: humana